High levels of respiratory syncytial virus (RSV)-specific nasal IgA also correlate with protection against experimental RSV infection [15], and the same was found for HCoV-229E, with subjects that carry high pre-infection IgA concentrations remaining uninfected after experimental nasal inoculation with an HCoV-229E virus culture [4,16]. This evidence concerns the gene CD79A and infection.